VERTEX PHARMACEUTICALS INC / MA 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Jun 23, 2008
Insider Transaction Report
Form 4
ALAM JOHN J
SVP, Drug Eval. & Appr.
Transactions
- Exercise/Conversion
Common Stock
2008-06-19$15.87/sh+4,822$76,525→ 133,333 total - Exercise/Conversion
Stock Option
2008-06-19−4,822→ 0 totalExercise: $15.87From: 2002-10-22Exp: 2012-07-21→ Common Stock (4,822 underlying) - Exercise/Conversion
Common Stock
2008-06-19$15.60/sh+3,459$53,960→ 136,792 total - Exercise/Conversion
Stock Option
2008-06-19−3,459→ 0 totalExercise: $15.60From: 2003-04-18Exp: 2013-01-17→ Common Stock (3,459 underlying)
Holdings
- 5,140(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years.